The Eric Ries Show cover image

His First Company Went Public For $3.5 Billion, Now He’s Reversing Type 2 Diabetes For 100 Million

The Eric Ries Show

CHAPTER

Rethinking GLP-1 Medications for Long-Term Health

Exploring the potential of GLP-1 drugs in treating diabetes and obesity while emphasizing concerns about their long-term effects. The chapter advocates for a shift towards nutrition and behavioral changes as a primary strategy over lifelong medication dependence.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner